Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase A in Patients With Fabry Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02995993
Recruitment Status : Completed
First Posted : December 19, 2016
Last Update Posted : December 13, 2017
Sponsor:
Collaborator:
FGK Clinical Research GmbH
Information provided by (Responsible Party):
Greenovation Biotech GmbH